Common GLP-1s include semaglutides like Ozempic and Wegovy, and tirzepatides like Zepbound and Mounjaro. These drugs work by mimicking a natural hormone to regulate appetite, blood sugar, and feelings ...

After nearly two years, federal regulators announced the shortage of the active ingredient in Mounjaro and Zepbound has been resolved. Tirzepatide, the active ingredient in the diabetes and obesity ...

Compared with rival injectables Wegovy and Ozempic (semaglutide), Zepbound leads to greater weight loss. Learn about how it works, pricing, and side effects.

Losing muscle, as well as fat, is an unexpected downside of the popular drugs that isn’t broadly discussed or immediately ...

Eli Lilly's blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro posted weaker-than-expected sales for the third quarter, even as both medicines have largely recovered from widespread ...

Add Yahoo as a preferred source to see more of our stories on Google. Consumers who take copies of the popular weight loss and diabetes drug tirzepatide will likely need to find a new source for these ...

Add Yahoo as a preferred source to see more of our stories on Google. A sign for the Food and Drug Administration is seen on July 20, 2020, at the White Oak campus in Silver Spring, Maryland. (Sarah ...

Lilly hiked its full-year sales outlook by $2 billion, and also raised its adjusted profit guidance.

Eli Lilly is experiencing explosive growth thanks to its diabetes and obesity treatments. Beyond weight loss, the company is quietly building a fast-growing oncology business. This is an enormous ...

Consumers who take copies of the popular weight loss and diabetes drug tirzepatide will likely need to find a new source for these medications early next year. On Thursday, the Food and Drug ...